Sentence examples for weight medium from inspiring English sources

A population balance model for flocculation of PCC particles with polyelectrolytes of very high molecular weight, medium charge density and different degree of branching is presented.

According to the experimental conditions, i.e. dextran molar weight, medium temperature and reaction time, HMDS/OH ratio, addition of a catalyst and co-solvent, partially or totally silylated dextrans were recovered.

The rate and extent of lipid digestion were found to increase with: increasing lipase (from 0 to 4.8 mg/ml), decreasing bile extract (from 20 to 0 mg/ml), increasing CaCl2 (from 0 to 20 mM), decreasing lipid (from 2.5 to 0.1 wt.%); decreasing droplet diameter (from d = 800 to 200 nm), and decreasing fatty acid molecular weight (medium chain triglycerides versus corn oil).

Weight: Medium weight, at 10.8 lb.

ICR mice (18 22 g) were divided into five groups (both sexes, six per group) and orally administered extract solvents (control), low dose TMHE (20 mg/kg body weight), medium dose TMHE (40 mg/kg body weight), high dose TMHE (80 mg/kg body weight), and dabigatran etexilate (20 mg/kg body weight).

ICR mice (18 22 g) were divided into five treatment groups (both sexes, six per group) and orally administered extract solvents (control), low dose TMHE (20 mg/kg body weight), medium dose TMHE (40 mg/kg body weight), high dose TMHE (80 mg/kg body weight), and dabigatran etexilate (Boehringer Ingelheim, 20 mg/kg body weight).

Plasma adiponectin (total, high-molecular weight, medium-molecular weight, and low-molecular weight) were measured by ELISA (ALPCO diagnostics); low-molecular weight adiponectin was obtained by subtracting the combined concentration of medium-molecular weight and high-molecular weight adiponectin (measured directly) from the total adiponectin concentration.

A low-molecular weight contrast medium and a blood pool contrast medium were used.

The low molecular weight contrast medium Gadovist® as well as the high molecular weight contrast medium Gadomer® resulted in an equivalent accumulation within the vascular system.

For imaging studies of the blood flow within the tumour two different contrast media were used: the low molecular weight contrast medium gadobutrol (Gadovist®, Bayer Schering Pharma, Berlin, Germany) and the high molecular weight contrast medium gadolinium-DTPA (Gadomer®, Bayer Schering Pharma, Berlin, Germany).

The low molecular weight contrast medium Gadovist® as well as the high molecular weight contrast medium Gadomer® can be used for dynamic contrast enhanced imaging of the tumour blood flow and for analyzing different factors that might influence tumour blood flow.